Hints and tips:
Related Special Reports
...The move follows pledges by Novartis and Sanofi to work with BioNTech/Pfizer to help produce their vaccine....
...IP is not the limiting factor at this stage, says David Loew, executive vice-president at Sanofi Pasteur. “Most vaccines don’t even have IP....
...Sanofi and Eli Lilly, which are investigating vaccines and potential treatment candidates, did not respond to requests for comment....
...At the same time, we completed the filing of our breakthrough innovation Dupixent for the first indication, atopic dermatitis, in the U.S and Europe....
...(FT) UK care crisis The general election campaign was dominated by a Conservative U-turn over social care plans, dubbed a “dementia tax” by opponents....
...Since the turn of the year, eurozone yields have plummeted, a decline fuelled initially by market turmoil and risk aversion, as well as falling inflation expectations, a dovish u-turn from the Fed and a...
...not a household name, its fight against the FDA was backed by a consortium of 11 of the biggest names in the pharmaceuticals industry — including Johnson & Johnson, Pfizer, GlaxoSmithKline, Novartis and Sanofi...
...Three cancer drugs that were supposed to be removed from the National Health Service on cost grounds have been granted a reprieve in a partial U-turn by health authorities....
...The U-turn comes at a difficult time for GSK as it battles falling US sales in its core respiratory drugs business as well as the fallout from a corruption scandal in China....
...Markets: “Asian stocks swung between gains and losses as investors weighed corporate earnings before the Federal Reserve decides on U.S. monetary policy....
...Earnings American International Group Q1 $1.07 ($1.34) Pfizer Q1 $0.55 ($0.54) Shareholder meeting Sanofi ● Antony Jenkins faces a crucial week....
...Tullow to invest $4 bn in Ghana to increase its crude oil production Tullow Oil a U.K. explorer with the most licenses in Africa, may invest at least $4 bn with its partners to develop oil fields off Ghana...
...From Market Watch: French pharmaceuticals major Sanofi-Aventis SA confirmed Wednesday it has struck a deal to buy U.S. peer Genzyme Corp....
...Glenmark Pharma in licensing deal with Sanofi Glenmark Pharmaceuticals said on Monday its unit has entered into an agreement with Sanofi to grant a licence for the development and commercialisation of GBR...
...of some of sanofi-aventis’ Prescription Medicines to Over-the-Counter Products – Chattem Management to Lead the U.S....
...The bodies collaborating on the RV144 trial in Thailand – including the US Army and National Institutes of Health, the Thai health ministry and Sanofi Aventis, the giant French drug company – could hardly...
...This outcome is the result of mutual misunderstanding and a remarkable strategic U-turn by Siemens....
...The concern with the Sanofi vaccine so far is that the quantity necessary to prove effective in protecting against the virus was extremely high: about six times the normal dose required for protection from...
International Edition